FDA今年十月剛批準的療法（CAR T-cell therapy），但是有條件限製。煩請各位好人幫忙看一下。

這樣，我好對照朋友情況看看她是否適合接受這種治療。

 

Conditions treated

The FDA-approved indications for CAR T-cell therapy, Yescarta made by Kite Pharma Gilead, is aggressive B-cell non-Hodgkin's lymphoma, including the diagnosis of:

• Diffuse large B-cell lymphoma
• Primary mediastinal B-cell lymphoma
• Large B-cell lymphoma transformed from follicular lymphoma
• Aggressive B-cell lymphoma not otherwise specified (NOS)

Patients who have relapsed or refractory disease after two or more types of prior treatments could be evaluated for CAR T-cell therapy with Yescarta.

In addition, Mayo Clinic has multiple active clinical trials testing CAR T-cell therapy in lymphoma and other cancer types.

 

請問：

“including the diagnosis of:

• Diffuse large B-cell lymphoma
• Primary mediastinal B-cell lymphoma
• Large B-cell lymphoma transformed from follicular lymphoma
• Aggressive B-cell lymphoma not otherwise specified (NOS)”

這段話是什麽意思啊？是這種療法要做的事？這種療法需要的前提？還是這種療法需要確診上述問題？

拜謝！